SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-24-000024
Filing Date
2024-02-28
Accepted
2024-02-28 16:08:00
Documents
16
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-20240228.htm   iXBRL 8-K 25031
2 EX-99.1 rna-2024228xexx991.htm EX-99.1 73320
6 gfnzizaxnpmk000001.jpg GRAPHIC 206622
  Complete submission text file 0001599901-24-000024.txt   486825

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20240228.xsd EX-101.SCH 1931
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20240228_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20240228_pre.xml EX-101.PRE 13067
17 EXTRACTED XBRL INSTANCE DOCUMENT rna-20240228_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 24695301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)